Gemcitabine 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. and is intended for intravenous administration.

Gemcitabine is a chemotherapy drug commonly used in the treatment of certain types of cancer. It works by interfering with the growth and spread of cancer cells in the body. The specific uses of Gemcitabine may vary depending on the type and stage of cancer being treated. Always consult a healthcare provider to determine if Gemcitabine is appropriate for your condition.

Common effects of Gemcitabine may include fatigue, nausea, and a decreased appetite. Some individuals may also experience hair loss, skin reactions, or changes in blood cell counts. These effects can vary from person to person and may not affect everyone who uses this medication.

Gemcitabine should be handled with care, as it is a potent medication. It is important to follow proper safety protocols when administering this drug to avoid contamination or accidental exposure. Always store Gemcitabine in a secure and controlled environment, and dispose of any unused portions according to local regulations.

Gemcitabine may interact with other medications, including certain chemotherapy drugs and radiation therapy. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, Gemcitabine should not be mixed with other drugs in the same infusion line without medical supervision.